Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles

被引:394
作者
Bosch, E. [1 ]
Labarta, E. [1 ]
Crespo, J. [1 ]
Simon, C. [1 ]
Remohi, J. [1 ]
Jenkins, J. [2 ]
Pellicer, A. [1 ]
机构
[1] Univ Valencia, Inst Valenciano Infertilidad, Dept Reprod, Valencia 46015, Spain
[2] Ferring Pharmaceut, St Prex, Switzerland
关键词
progesterone; in vitro fertilization; intracytoplasmic sperm injection; GnRH analogues; ongoing pregnancy rate; HUMAN CHORIONIC-GONADOTROPIN; ELEVATED SERUM PROGESTERONE; HIGHLY PURIFIED HMG; INTRACYTOPLASMIC SPERM INJECTION; LATE FOLLICULAR PHASE; PREMATURE LUTEINIZATION; RECOMBINANT FSH; HORMONE AGONIST; PREDICT PREGNANCY; EMBRYO-TRANSFER;
D O I
10.1093/humrep/deq125
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The influence of elevated serum progesterone levels during in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles on pregnancy rates is a matter of continued debate among fertility clinicians. Efforts to resolve this question have been impeded by the various assays used to measure progesterone and the different, arbitrary threshold values for defining 'high' progesterone levels. A non-interventional, retrospective, observational, single-centre cohort study evaluated the relationship between serum progesterone levels on the day of human chorionic gonadotrophin (hCG) administration and the ongoing pregnancy rate in 4032 patients undergoing IVF/ICSI cycles using gonadotrophin-releasing hormone (GnRH) analogues for pituitary down-regulation. Ongoing pregnancy rates were inversely associated with serum progesterone levels on the day of hCG (P < 0.001 for overall trend), irrespective of the GnRH analogue used for pituitary down-regulation. Patients with serum progesterone levels < 1.5 ng/ml had significantly higher ongoing pregnancy rates than those with progesterone levels > 1.5 ng/ml (31.0 versus 19.1%; P = 0.00006); odds ratio, 0.53 (95% confidence interval, 0.38-0.72). Multivariate regression analysis showed that daily follicle-stimulating hormone dose, number of oocytes and estradiol values on the day of hCG administration were positively associated with progesterone levels (P < 0.0001 for all). Serum progesterone levels were significantly greater in women treated with GnRH agonists (n = 1177) versus antagonists (n = 2855; 0.84 +/- 0.67 versus 0.75 +/- 0.66 ng/ml; P = 0.0003). Elevated serum progesterone levels on the day of hCG administration is associated with reduced ongoing pregnancy rates. In particular, serum progesterone levels of > 1.5 ng/ml were associated with lower ongoing pregnancy rates following IVF/ICSI cycles irrespective of the GnRH analogue used for pituitary down-regulation.
引用
收藏
页码:2092 / 2100
页数:9
相关论文
共 47 条
[1]   Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer [J].
Abuzeid, MI ;
Sasy, MA .
FERTILITY AND STERILITY, 1996, 65 (05) :981-985
[2]   Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone [J].
Adonakis, G ;
Deshpande, N ;
Yates, RWS ;
Fleming, R .
FERTILITY AND STERILITY, 1998, 69 (03) :450-453
[3]   Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis [J].
Al-Inany, Hesham G. ;
Abou-Setta, Ahmed M. ;
Aboulghar, Mohamed A. ;
Mansour, Ragaa T. ;
Serour, Gamal I. .
GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (06) :372-378
[4]   Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial [J].
Andersen, Anders Nyboe ;
Devroey, Paul ;
Arce, Joan-Carles .
HUMAN REPRODUCTION, 2006, 21 (12) :3217-3227
[5]   Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study [J].
Bosch, E. ;
Vidal, C. ;
Labarta, E. ;
Simon, C. ;
Remohi, J. ;
Pellicer, A. .
HUMAN REPRODUCTION, 2008, 23 (10) :2346-2351
[6]   Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome [J].
Bosch, E ;
Escudero, E ;
Crespo, J ;
Simón, C ;
Remohí, J ;
Pellicer, A .
FERTILITY AND STERILITY, 2005, 84 (05) :1529-1532
[7]   Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome [J].
Bosch, E ;
Valencia, W ;
Escudero, E ;
Crespo, J ;
Simón, C ;
Remohi, J ;
Pellicer, A .
FERTILITY AND STERILITY, 2003, 80 (06) :1444-1449
[8]   Comment on: Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis [J].
Bosch, Ernesto .
HUMAN REPRODUCTION UPDATE, 2008, 14 (02) :194-195
[9]   The endometrium in stimulated cycles for IVF [J].
Bourgain, C ;
Devroey, P .
HUMAN REPRODUCTION UPDATE, 2003, 9 (06) :515-522
[10]   Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer [J].
Bustillo, M ;
Stern, JJ ;
Coulam, CB .
HUMAN REPRODUCTION, 1995, 10 (11) :2862-2867